1/67
UIowa MICR:2157 Fall '25 Unit 4 Exam
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
Sickle Cell Disease
Autosomal Recessive disorder
Makes RBCs sickle-shaped & difficult to travel through capillaries
Mutated gene for hemoglobin via single bp substitution
CRISPR Discovery
Found directed repeats with dyad symmetry in E. coli
These regions were found in 10 different bacteria, archaea, and mitochondria
CRISPR repeats are separated by nonhomologous spacers, and 4 Cas proteins predicted
Phage-resistant strains in bacteria used in food production showed spacers homologous to genomes of phage
CRISPR Function
tracrRNA + crRNA direct Cas 9 to cut target DNA at a region that bp with crRNA
repaired via NHEJ (deletion) or HR (editing)
CRISPR to correct sickle cell disease
BCL11A binds and represses gamma-globulin, repressing fetal Hb expression
Cas9 edits non-coding region of BCL11A, repressing expression
Principles for the governance of human genome editing
Promoting Well-being
Responsible science
Due care
Transparency
Respect for persons
Fairness
Transnational cooperation
Regulation for Germline Genome Editing
Absence of reasonable alternatives
Existing preclinical data supports efforts
Vigorous ongoing oversight and transparency
Long-term multigenerational and population studies
Basic CRISPR Research
Discovery of strange loci in the genomes of bacteria and archaea
Elucidating the role of CRISPR in defense against phage
Investigating the mechanism of CRISPR-mediated cuts to DNA
Translational CRISPR Research
Engineering sgRNA to direct CRISPR to target any sequence
Evaluating the ability of CRISPR to cut DNA in human cell lines
Clinical CRISPR Research
Demonstrating CRISPR can modify cells of patients with genetic disorders as a therapy
PCR Ingredients & Reaction
Primers, DNA Pol, template DNA, dNTPs, buffer
Denaturation: >94C, breaks H bonds
Annealing: 55-72C, primers bind
Extension: 68-72C, DNA Pol copies the template
Restriction Enzyme Discovery
Derived from bacteria, function as defense against phage infection
Cleaves unmethylated DNA at specific nucleotide sequences
Multiple Cloning Site
Region where plasmid can be cut to have complementary overhangs to the insert
Chemical Competence
Exposure of E. coli to CaCl2 makes it competent in the presence of a heat shock
Electrical Competence
exposure of E. coli to cold water washes makes it take up DNA when zapped with electric shock
Agrobacterium tumefaciens
Forms a parasitic symbiosis with plants, causing crown gall disease
Crown galls are plant tumors induced by A. tumefaciens tumor induction plasmid
T-DNA can be modified to insert foreign genes into plants (Bt toxin, etc.)
Virus Characteristics
Acellular
Obligate Intracellular Parasites
Shared structure (nucleic acids + capsid)
Host range
Spectrum of hosts that a pathogen can infect
Depends upon susceptibility and permissibility
Virion structure
Virion = mature virus particle, nucleocapsid
Nucleic Acids = DNA or RNA
Capsid = protomers that form capsomeres
Capsid shapes
Helical = protomers form rigid, hollow tube
Icosahedral = regular polyhedron, composed of capsomeres made of 5-6 protomers
Complex symmetry = not helical or icosahedral, poxviruses + complex phage
Naked Capsid vs. Enveloped Viruses
Naked capsid = only nucleocapsid, infectious outside the body longer than enveloped
Enveloped = nucleocapsid + envelope, require bodily fluids for transmission
Lipid bilayer acquired from host + glycoprotein/spikes
Lysozyme
Often encoded by phage
Makes a hole to allow for entry of nucleic acids, also produced to lyse the host cell
Neuraminidase
Spike protein encoded by influenza
Enzymatic activity supports separation of envelope from host cell during release
The Baltimore Scheme
Groups viruses based on the relationship between genomes and mRNA
Should not be used to describe relationships between viruses
One-step Growth Curve
Eclipse Phase - No virions detected in or outside of cells
Maturation - Packaging of nucleic acids in capsids, first virions detected
Burst Size = number of virions released
Latent Period = Eclipse + Maturation
Viral Replication Cycle
Attachment = ligand on virion attaches to receptor on host cell
Entry = genome alone or entire nucleocapsid enters host cell
Synthesis = viral nucleic acids synthesized/replicated and viral proteins synthesized
Assembly = nucleic acids packaged in the capsid
Release = host cell lysis or budding
Bacteriophage Structure
Icosahedral capsid head, housing nucleic acids
Sheath/tail: helical capsid, contracts to deliver tail tube through bacterial cell wall
Tail fibers: associate with host cell receptors
Tail pins: associate with cell wall to hold tail close to penetration site
Baseplate: mediates attachment, sheath contraction, phage DNA ejection
Virulent vs. Temperate Phage
Virulent = lytic cycle leads to lysis of cell
Temperate = reproduces using the lytic or lysogenic cycles
Induction can end the lysogenic phase + induce lytic cycle
T4 Phage
Model virulent phage, infects E. coli
Attaches to LPS
Lysozyme forms a pore to inject dsDNA into host
Synthesis of replication enzymes (early) + head, tail, lysis proteins (late)
Structural proteins + nucleic acids assemble into virions
Lysozyme lyses host cell
Prophage
Phage genome integrated into bacterial host chromosome
Mediated by recombinase/integrase
Phage Conversion
Phage infection changes the properties of the cell
Generalized transduction - any gene in bacterial genome is packaged in the virion
Specialized transduction - genes near insertion site are repeatedly packaged along with phage DNA
Toxin-antitoxin systems
Antitoxin inhibits induction of cell death by phage toxin
Abortive infection - phage DNA inactivated antitoxin, leading to cell death
Prevents more virions from spreading, protecting the population
CRISPR as a defense against phage
Cas proteins recognize protospacer adjacent motifs (PAMs) in DNA
Cas proteins cleave near PAM, inserting short piece of DNA into the chromosome
Results in “immunization”; Cas proteins destroy DNA with same protospacer
Fecal Indicators
Ex. coliphage/coliforms
Detects fecal contamination in food, water, treated wastewater
Survive as well or better than pathogens in the substance suspected of contamination
Easy to detect + present in high concentrations in feces
Animal Virus Attachment
Ligand on virion attaches to receptor on host cell
Specificity of ligand to receptor determines tropism (specificity of virus to particular cell/tissue)
Animal Virus Entry
Fusion: envelope is left at the host cell membrane or at the endosome (receptor-mediated endocytosis)
Uncoating: removal of nucleocapsid due to enzyme/pH change in endosome or following escape
Animal Virus Release
Host cell lysis = viral proteins puncture host plasma membrane
Budding = occurs at the same time as envelope formation, viral proteins incorporated into membrane
dsDNA Viruses
Nucleic acid synthesis occurs in nucleus
Replication: dsDNA → dsDNA
Transcription/translation: dsDNA → mRNA → Protein
Tegument
layer of proteins between nucleocapsid + envelope
Productive infection
Cell lyses, releasing 50,000 - 200,000 virions
Latent infection
Virions are undetected, can reactivate after months/years
Viral genomes remain in cells w/o virion production as proviruses or extrachromosomal elements
Persistent/Chronic infection
Slow increase in viral load, can reactivate after months/years
The cell is not lysed but remains a viral factory
Includes cytopathic effects (changes in host cells and tissues that are distinct from lysis)
dsRNA Viruses
Nucleic acid synthesis occurs in cytoplasm
Replication: dsRNA → ssRNA → dsRNA
Transcription/translation: dsRNA → mRNA → Protein
Needs Rdrp
Positive Sense Viruses
Nucleic acid synthesis occurs in cytoplasm
Replication: +RNA → -RNA → +RNA
Transcription/translation: +RNA → Protein
Needs Rdrp
Negative Sense Viruses
Nucleic acid synthesis occurs in cytoplasm (influenza in nucleus)
Replication: -RNA → +RNA → -RNA
Transcription/translation: -RNA → mRNA → Protein
Needs Rdrp, packaged in virion
Retroviruses
Nucleic acid synthesis occurs in the cytoplasm (RNA → DNA) and nucleus (DNA integration)
Replication: +RNA → ssDNA → dsDNA → +RNA
Transcription/translation: DNA → mRNA → Protein
Reverse transcriptase and Integrase needed
Proteins that viruses encode for
Nonstructural Proteins (NSP): enzymes for viral processes (Rdrp, reverse transcriptase)
Structural proteins (SP): spike/glycoproteins
Accessory proteins (AP): Interfering with cellular processes and the innate immune response
Hemagglutinin Spikes (HA)
Attaches to sialic acid moieties linked to glycoproteins and glycolipids on cells in the respiratory epithelium
Neuraminidase Spikes (NA)
Facilitates induction of receptor mediated endocytosis and separation of the virus from the host cell during budding
Cytocidal infection
Disease in which some of the symptoms result from cell death
Oncogenic viruses
Activate/insert oncogenes, inactivate tumor suppressor genes, cause chronic inflammation
Cytokines
Soluble, low molecular weight protein or glycoprotein that acts as an intracellular signaling molecule
Used by immune response to communicate
Cytokine storms
Dilation of blood vessels, rapid drop in blood pressure, leading to shock
Can also overstimulate fever-inducing pathways, causing unregulated blood clotting
Immune Response to viral infections
Complement proteins → opsonization → phagocytosis
NK cells → look for absence of MHC I or cells tagged with antibodies
Interferons → cytokines produced by infected cells that promote antiviral pathways in neighboring cells
Production of neutralizing antibodies
Cytotoxic T cells → check MHC I signals → induce apoptosis of infected cells
Treatments for viral infection
Neuraminidase inhibitors: inhibit enzymatic activity of NA spikes
Nucleoside/mononucleotide analogs: inhibit DNA viruses which use their own enzyme to phosphorylate nucleotides (incorporation of analogs halts DNA synthesis)
Nucleoside RT inhibitors: inhibit retroviruses by incorporating into DNA during reverse transcription, halting synthesis
Nonnucleoside RT inhibitors: bind to and inhibit reverse transcriptase
Protease inhibitors: block HIV protease (required for protein synthesis)
Integrase inhibitors: prevent DNA integration
Fusion inhibitors: prevent entry
Types of cell lines
Primary: used for viral growth, die after a few generations
Diploid: developed from human embryos, can be maintained for hundreds of generations
Continuous/immortal: cancerous cells, can be maintained indefinitely
Serology
Detection of presence of antibodies specific to pathogen of interest in patient’s serum (ELISA)
Lateral flow/rapid antigen assays
Detect presence of specific antigen using labeled & unlabeled antibodies
Multiplex PCR
multiple primers used in the same rxn to determine the causal agent
Reverse transcriptase PCR
For RNA viruses
RT enzyme makes cDNA, which is then amplified via PCR
Influenza virus
Antisense RNA genome
Enveloped
NA & HA spikes used to designate types
Antigenic drift
Accumulation of point mutations (error-prone Rdrp)
As mutations accumulate, transmission increases & pathogenicity decreases
Antigenic shift
reassortment of influenza genomes in a “mixing vessel” due to co-infection of two different flu strains in the same cell
Plant viruses
Have a wider host range
Prions
Infectious protein that induces progressive degeneration of the brain & eventual death
PrPc (cellular prion protein): localized in neuron plasma membrane, brain development/function
PrPsc (scrapie-associated PrPc): same AA sequence as PrPc but has been irreversibly misfolded
Can cause PrPc to misfold following direct contact
Aggregates and causes degeneration
Scrapie
Prion disease first described in sheep in 1732
Variant Creutzfeldt-Jakob disease
Prion disease first observed in humans in 1920
Transmitted by ingesting infected cows (mad cow disease)
Kuru
Prion disease first described in 1959 in Papau New Guinea
Chronic Wasting Disease
Prions disease that effects deer, elk, reindeer, sika deer, moose